Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
- PMID: 28206827
- PMCID: PMC5405816
- DOI: 10.1177/1352458517690821
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
Abstract
Cognitive and motor performance measures are commonly employed in multiple sclerosis (MS) research, particularly when the purpose is to determine the efficacy of treatment. The increasing focus of new therapies on slowing progression or reversing neurological disability makes the utilization of sensitive, reproducible, and valid measures essential. Processing speed is a basic elemental cognitive function that likely influences downstream processes such as memory. The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with MS. Among the MSOAC goals is acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful to persons with MS. A critical step for these neuroperformance metrics is elucidation of clinically relevant benchmarks, well-defined degrees of disability, and gradients of change that are deemed clinically meaningful. This topical review provides an overview of research on one particular cognitive measure, the Symbol Digit Modalities Test (SDMT), recognized as being particularly sensitive to slowed processing of information that is commonly seen in MS. The research in MS clearly supports the reliability and validity of this test and recently has supported a responder definition of SDMT change approximating 4 points or 10% in magnitude.
Keywords: Multiple sclerosis; Symbol Digit Modalities Test; cognition; performance outcome; processing speed; psychometric validity.
Conflict of interest statement
Figures


Comment in
-
The measure tells the tale: Clinical outcome measures in multiple sclerosis.Mult Scler. 2017 Apr;23(5):626-627. doi: 10.1177/1352458517690825. Epub 2017 Feb 16. Mult Scler. 2017. PMID: 28206813 No abstract available.
Similar articles
-
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.Mult Scler. 2017 Apr;23(5):711-720. doi: 10.1177/1352458517690824. Epub 2017 Feb 16. Mult Scler. 2017. PMID: 28206826 Free PMC article.
-
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.Mult Scler. 2017 Apr;23(5):704-710. doi: 10.1177/1352458517690823. Epub 2017 Feb 16. Mult Scler. 2017. PMID: 28206828 Free PMC article.
-
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.Mult Scler. 2017 Apr;23(5):734-747. doi: 10.1177/1352458517690822. Epub 2017 Feb 16. Mult Scler. 2017. PMID: 28206829 Free PMC article. Review.
-
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.Mult Scler. 2019 Nov;25(13):1781-1790. doi: 10.1177/1352458518808204. Epub 2018 Oct 18. Mult Scler. 2019. PMID: 30334474 Free PMC article.
-
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.Mult Scler. 2014 Jan;20(1):12-7. doi: 10.1177/1352458513503392. Epub 2013 Sep 20. Mult Scler. 2014. PMID: 24057430 Review.
Cited by
-
Cognitive Impairment in Multiple Sclerosis: An Update on Assessment and Management.NeuroSci. 2022 Nov 22;3(4):667-676. doi: 10.3390/neurosci3040048. eCollection 2022 Dec. NeuroSci. 2022. PMID: 39483763 Free PMC article. Review.
-
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis.Eur J Neurol. 2021 Jun;28(6):2037-2045. doi: 10.1111/ene.14829. Epub 2021 Apr 2. Eur J Neurol. 2021. PMID: 33735479 Free PMC article.
-
Cognitive trajectories in multiple sclerosis: a long-term follow-up study.Neurol Sci. 2022 Feb;43(2):1215-1222. doi: 10.1007/s10072-021-05356-2. Epub 2021 Jun 8. Neurol Sci. 2022. PMID: 34105018 Free PMC article.
-
Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study.JMIR Mhealth Uhealth. 2020 Oct 5;8(10):e18160. doi: 10.2196/18160. JMIR Mhealth Uhealth. 2020. PMID: 33016886 Free PMC article.
-
Neural precursor cells tune striatal connectivity through the release of IGFBPL1.Nat Commun. 2022 Dec 8;13(1):7579. doi: 10.1038/s41467-022-35341-y. Nat Commun. 2022. PMID: 36482070 Free PMC article.
References
-
- Charcot JM. Lectures on the Diseases of the Nervous System. London: New Sydenham Society, 1877.
-
- Rao SM, Leo GJ, St Aubin-Farbert P. Information processing speed in patients with multiple sclerosis. J Clin Exp Neuropsychol 1989; 11: 471–477. - PubMed
-
- Peyser JM, Rao SM, LaRocca NG, et al. Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 1990; 47: 94–97. - PubMed
-
- Rao SM, Leo GJ, Bernardin L, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685–691. - PubMed
-
- Gronwall DMA. Paced auditory serial addition task: A measure of recovery from concussion. Percept Mot Skills 1977; 44: 367–373. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials